Palma, David A.

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Gomez, D. R., Blumenschein, G. R., Lee, J. J., Hernandez, M., Ye, R., Camidge, D. R., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Gibbons, D. L., et al. (2016) · The Lancet Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 1,086

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer

Ashworth, A. B., Senan, S., Palma, D. A., Riquet, M., Ahn, Y. C., Ricardi, U., Congedo, M. T., Gomez, D. R., Wright, G. M., Melloni, G., et al. (2014) · Clinical Lung Cancer

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations

Cited by 435

Frequent Mutations in TP53 and CDKN2A Found by Next-Generation Sequencing of Head and Neck Cancer Cell Lines

Nichols, A. C., Yoo, J., Palma, D. A., Fung, K., Franklin, J. H., Koropatnick, J., Mymryk, J. S., Batada, N. N., & Barrett, J. W. (2012) · Archives of Otolaryngology–Head & Neck Surgery

Head and Neck Cancer StudiesCancer Genomics and Diagnostics

Cited by 47

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer

Ghasemi, F., Black, M., Vizeacoumar, F., Pinto, N., Ruicci, K. M., Le, C. C. S. H., Lowerison, M. R., Leong, H. S., Yoo, J., Fung, K., et al. (2017) · Oncotarget

Head and Neck Cancer StudiesHistone Deacetylase Inhibitors Research

Cited by 38

Delay in Diagnosis of Patients with Head-and-Neck Cancer in Canada: Impact of Patient and Provider Delay

Kassirian, S., Dzioba, A., Hamel, S., Patel, K., Sahovaler, A., Palma, D. A., Read, N., Venkatesan, V., Nichols, A. C., Yoo, J., et al. (2020) · Current Oncology

Head and Neck Cancer StudiesCOVID-19 and healthcare impacts

Cited by 36